![]() |
UMIN-CTR Clinical Trial |
|
![]() |
![]() |
![]() |
![]() |
Name: | UMIN ID: |
Recruitment status | No longer recruiting |
Unique ID issued by UMIN | UMIN000040063 |
Receipt No. | R000045682 |
Scientific Title | Periodical difference of SFA intervention -Multi center retrospective analysis- |
Date of disclosure of the study information | 2020/04/10 |
Last modified on | 2020/04/05 |
Basic information | ||
Public title | Periodical difference of SFA intervention
-Multi center retrospective analysis- |
|
Acronym | MK4 study | |
Scientific Title | Periodical difference of SFA intervention
-Multi center retrospective analysis- |
|
Scientific Title:Acronym | MK4 study | |
Region |
|
Condition | |||
Condition | Symptomatic Superficial femoral artery (SFA) atherosclerosis occlusive disease | ||
Classification by specialty |
|
||
Classification by malignancy | Others | ||
Genomic information | NO |
Objectives | |
Narrative objectives1 | To evaluate the real-world endovascular treatment therapy for SFA AIOD |
Basic objectives2 | Safety,Efficacy |
Basic objectives -Others | |
Trial characteristics_1 | |
Trial characteristics_2 | |
Developmental phase |
Assessment | |
Primary outcomes | Primary patency rate |
Key secondary outcomes | Free from target lesion revascularization rate, Amputation free rate, all-cause mortality rate |
Base | |
Study type | Observational |
Study design | |
Basic design | |
Randomization | |
Randomization unit | |
Blinding | |
Control | |
Stratification | |
Dynamic allocation | |
Institution consideration | |
Blocking | |
Concealment |
Intervention | |
No. of arms | |
Purpose of intervention | |
Type of intervention | |
Interventions/Control_1 | |
Interventions/Control_2 | |
Interventions/Control_3 | |
Interventions/Control_4 | |
Interventions/Control_5 | |
Interventions/Control_6 | |
Interventions/Control_7 | |
Interventions/Control_8 | |
Interventions/Control_9 | |
Interventions/Control_10 |
Eligibility | ||||
Age-lower limit |
|
|||
Age-upper limit |
|
|||
Gender | Male and Female | |||
Key inclusion criteria | From 2010-2018,
Successfully EVT for SFA lesions Rutherford category 2-4 de novo lesions |
|||
Key exclusion criteria | Rutherford 5-6
In stent restenosis |
|||
Target sample size | 2800 |
Research contact person | |||||||
Name of lead principal investigator |
|
||||||
Organization | Kishiwada Tokushukai Hospital | ||||||
Division name | Cardiology | ||||||
Zip code | 595-8522 | ||||||
Address | 4-27-1,Kamori-cho,Kishiwada City Osaka,Japan | ||||||
TEL | 072-445-9915 | ||||||
masahiko-fujihara@themis.ocn.ne.jp |
Public contact | |||||||
Name of contact person |
|
||||||
Organization | Kishiwada Tokushukai Hospital | ||||||
Division name | Cardiology | ||||||
Zip code | 595-8522 | ||||||
Address | 4-27-1,Kamori-cho,Kishiwada City Osaka,Japan | ||||||
TEL | 072-445-9915 | ||||||
Homepage URL | |||||||
masahiko-fujihara@themis.ocn.ne.jp |
Sponsor | |
Institute | Kishiwada Tokushukai Hospital |
Institute | |
Department |
Funding Source | |
Organization | None |
Organization | |
Division | |
Category of Funding Organization | Other |
Nationality of Funding Organization |
Other related organizations | |
Co-sponsor | |
Name of secondary funder(s) |
IRB Contact (For public release) | |
Organization | Kishiwada Tokushukai Hospital IRB |
Address | 4-27-1,Kamori-cho,Kishiwada City Osaka,Japan |
Tel | 072-445-9915 |
kenji.nakatani@tokushukai.jp |
Secondary IDs | |
Secondary IDs | NO |
Study ID_1 | |
Org. issuing International ID_1 | |
Study ID_2 | |
Org. issuing International ID_2 | |
IND to MHLW |
Institutions | |
Institutions | 岸和田徳洲会病院、小倉記念病院、関西労災病院、森之宮病院、済生会中津病院 |
Other administrative information | |||||||
Date of disclosure of the study information |
|
Related information | |
URL releasing protocol | |
Publication of results | Partially published |
Result | |
URL related to results and publications | |
Number of participants that the trial has enrolled | 2800 |
Results | |
Results date posted | |
Results Delayed | |
Results Delay Reason | |
Date of the first journal publication of results | |
Baseline Characteristics | |
Participant flow | |
Adverse events | |
Outcome measures | |
Plan to share IPD | |
IPD sharing Plan description |
Progress | |||||||
Recruitment status | No longer recruiting | ||||||
Date of protocol fixation |
|
||||||
Date of IRB |
|
||||||
Anticipated trial start date |
|
||||||
Last follow-up date |
|
||||||
Date of closure to data entry | |||||||
Date trial data considered complete | |||||||
Date analysis concluded |
Other | |
Other related information | Multicenter retrospective observational analysis |
Management information | |||||||
Registered date |
|
||||||
Last modified on |
|
Link to view the page | |
URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045682 |
Research Plan | |
Registered date | File name |
Research case data specifications | |
Registered date | File name |
Research case data | |
Registered date | File name |